PT  - JOURNAL ARTICLE
AU  - Rodgers, Aoife
AU  - Indreberg, Emilie Kruke
AU  - Alfallaj, Lenah
AU  - Nadkarni, Manasi
AU  - Kabir, Zubair
TI  - Are men who smoke at higher risk for a more severe case of COVID-19 than women who smoke? A Systematic Review
AID  - 10.1101/2020.06.18.20135111
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.06.18.20135111
4099  - http://medrxiv.org/content/early/2020/06/22/2020.06.18.20135111.short
4100  - http://medrxiv.org/content/early/2020/06/22/2020.06.18.20135111.full
AB  - Background The novelty of the Covid-19 pandemic is reflected in the lack of literature available for the impact of smoking on the intensity of the COVID-19 clinical manifestations. Our study tries to address this gap.Method Six cohorts from China were analysed and a crude odds ratio was manually calculated.Results Patients with a smoking history were approximately 2 times (95% CI= 1.036-1.883) as likely to suffer from severe clinical manifestations of COVID-19 compared to patients without a smoking history. A higher percentage of males suffer more severe symptoms of COVID-19 in comparison to females, but this could be associated with the gender specific smoking trends observed in China.Conclusion The gender specific smoking trends could be associated with the increased severity of COVID-19 disease manifestations in the male population.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo funding was available to this study.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:No ethical approval was necessaryAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData can be available on request.